Avapritinib With Decitabine in Patients With SM-AHN
Avapritinib With Decitabine in Patients With SM-AHN
Recruiting · NCT06327685 · Registry updated 2026-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Avapritinib With Decitabine in Patients With SM-AHN | Systemic Mastocytosis With an Associated Hematologic Neoplasm | Recruiting | Phase 1 | 2026-04-01 | NCT06327685 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Blueprint Medicines Corporation | 9 |
| H. Lee Moffitt Cancer Center and Research Institute | 162 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Mayo Clinic - Arizona | Phoenix | United States | 9 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Stanford University Medical Center | Palo Alto | United States | 10 |
| University of Michigan | Ann Arbor | United States | 538 |
| University of Utah Health | Salt Lake City | United States | 21 |